Anxiety-like behaviors are highly prevalent and frequently co-occur with metabolic conditions such as type 2 diabetes and obesity, suggesting the potential for shared biological mechanisms. Although glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are widely used for glycemic control and weight management, emerging evidence indicates that they may also influence neuroinflammation ...
If youre using a GLP-1 medication like Ozempic or Mounjaro, you probably started it for weight loss or diabetes management. But many of my clients report unexpected emotional challenges, such as anxiety or panic attacks, soon after beginning treatment.
This particular example perfectly highlights why Glp1 And Anxiety Management is so captivating.
